How Long Do You Take Wegovy? The Real Timeline for Weight Loss

Last reviewed: July 6, 2026

Last updated: July 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by activating GLP-1 receptors in your brain to reduce hunger and slow stomach emptying, but this process unfolds over weeks, not days. Understanding the realistic timeline for semaglutide therapy helps you set achievable expectations and commit to a treatment duration that actually works. PlexusDx patients often ask: how long will I need to take this medication, and when will I start seeing results?

When Do You First Notice Semaglutide Working?

Most people experience appetite suppression within the first 2 to 3 weeks of starting semaglutide, though some feel changes within days of their first dose. This early signal—reduced cravings or smaller portion sizes—isn't the same as measurable weight loss, but it confirms the medication is engaging your appetite-control pathways. The strength and timing of this initial response varies widely based on genetics, baseline metabolism, and dose escalation speed.

Noticeable weight loss typically begins around week 4 to 6 of consistent treatment, with most patients dropping 1 to 2 pounds per week during the initial phase. However, weight loss is rarely linear; some weeks show faster progress while others plateau as your body adjusts to lower calorie intake and improved satiety. Clinical trials show average weight reductions of 5% to 10% of baseline body weight within the first 3 months for patients in the 0.5 to 1.0 mg dose range.

The Typical Semaglutide Treatment Duration and Dose Escalation

Semaglutide treatment typically lasts 6 months to 2 years or longer, depending on your weight loss goals, response to therapy, and how your body tolerates the medication. Most structured programs follow a dose-escalation schedule that starts with the lowest effective dose and gradually increases over 16 to 20 weeks, allowing your body to adapt while minimizing side effects. PlexusDx's Microdose GLP-1 Protocol starts at an even gentler entry point for patients seeking minimal initial impact, while standard compounded semaglutide injections accommodate rapid or gradual titration based on your tolerance.

Your dose may need to go up as your body adapts, but your price won't—PlexusDx keeps compounded semaglutide injections flat at $189/mo (or $149/mo on the 6-month plan) across all commitment tiers. This pricing structure removes the financial anxiety of dose adjustments, letting you focus on finding the right therapeutic level without worrying about escalating costs. Most patients reach an effective maintenance dose of 0.5 to 1.0 mg weekly by month 4 or 5, though some require higher doses for maximal benefit.

How Long Should You Stay on Semaglutide Treatment?

Once you reach your target weight or desired body composition, the question shifts from 'How long until it works?' to 'How long do I stay on it?' Current evidence suggests that semaglutide works best as a long-term therapy rather than a short-term course; stopping abruptly often leads to rebound weight gain within months. Many patients benefit from ongoing maintenance therapy at a steady dose, sometimes reduced from their peak dose, to sustain the metabolic and appetite-control benefits they've achieved.

Some patients transition to periodic dosing or lower maintenance doses after 1 to 2 years, while others find indefinite treatment necessary to maintain their results and health improvements. The decision to continue, reduce, or discontinue semaglutide should be made collaboratively with a healthcare provider who understands your individual metabolic response and life circumstances. PlexusDx patients can adjust their therapy duration and dosing strategy at any point, supported by the Precision Peptide Genetic Test—which identifies your genetic predispositions in 14 metabolic pathways—to optimize long-term outcomes.

Real-World Timeline Expectations and Realistic Milestones

Weeks 1-4: Appetite suppression begins, nausea and GI adjustment are common, minimal weight change. Weeks 5-12: Steady weight loss of 1-2 pounds weekly, appetite control solidifies, energy may increase. Weeks 13-20: Cumulative weight loss of 5-15 pounds, plateau phases become visible, dose adjustments often occur. Months 5-12: Total weight loss of 10-25+ pounds depending on starting point and adherence, metabolic improvements show in labs.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I stop semaglutide after reaching my weight loss goal?

You can, but most people who stop experience weight rebound within 6 months because the underlying appetite and metabolic factors return. Many patients benefit from ongoing maintenance therapy at a lower dose to sustain results and health benefits over the long term.

What's the difference between taking semaglutide for 6 months versus 2 years?

Longer treatment typically yields greater total weight loss, stronger metabolic improvements, and more durable results because sustained behavior change and appetite suppression become more ingrained. However, the rate of weight loss often slows after 6-9 months, so adding months of therapy yields diminishing returns unless dosing is adjusted or combined with other interventions.

Does PlexusDx offer flexible treatment timelines and pricing?

Yes. PlexusDx serves all 50 states with no insurance required, no membership fees, and HSA/FSA eligibility. Compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan flat across all commitment tiers, meaning your price stays constant even if your dose increases—so you can extend or adjust your treatment timeline without unexpected cost jumps.

Are there side effects that improve over time on semaglutide?

Most common side effects—nausea, constipation, reduced appetite for certain foods—peak in weeks 2-4 and improve significantly by weeks 6-8 as your body acclimates. Starting low and titrating slowly, as PlexusDx protocols allow, reduces initial side effect severity and improves long-term tolerability and compliance.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.